SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Omt...
29 Maio 2013 - 8:13AM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Omthera Pharmaceuticals, Inc. (“Omthera” or the “Company”)
(NasdaqGM: OMTH) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to AstraZeneca Plc (NYSE: AZN).
Click here to learn more about the investigation
http://zlk.9nl.com/omthera-pharamaceuticals-omth/, or call:
877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Omthera shareholders will
receive $12.70 for each share of Omthera stock they own. In
addition, Omthera shareholders will receive approximately $4.70 in
contingent value rights if certain benchmarks are met. Including
the contingent rights, the transaction has a total approximate
value of $443 million. The investigation concerns whether the
Omthera Board of Directors breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into the transaction, whether AstraZeneca is
underpaying for Omthera stock, thus unlawfully harming Omthera
shareholders.
If you own common stock in Omthera and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit
http://zlk.9nl.com/omthera-pharamaceuticals-omth/.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey and Washington D.C. The firm has extensive
expertise in prosecuting securities litigation involving financial
fraud, representing investors throughout the nation in securities
and shareholder lawsuits. The attorneys at Levi & Korsinsky
have been appointed by numerous courts throughout the country to
serve as lead counsel on behalf of shareholders in major securities
lawsuits and have successfully recovered multimillion-dollar
damages awards on behalf of investors. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
OMTHERA PHARMACEUTICALS, INC. (NASDAQ:OMTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
OMTHERA PHARMACEUTICALS, INC. (NASDAQ:OMTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Omthera Pharmaceuticals, Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Omthera Pharmaceuticals, Inc. (MM)